Kentucky HBPA Issues Statement on Lasix Ban

POSTED ON  |  01-05-2019

Rick Hiles Kentucky HBPA
The Kentucky Horsemen’s Benevolent and Protective Association released a statement Monday in opposition to the announcement by several major racetrack operators of a phase-out of the use of Lasix. That Apr. 18 announcement called for phasing out the use of Furosemide (Lasix) beginning in 2-year-old-racing in January 2020 and eliminating the use of Lasix in black-type races held at their racetracks beginning the following year.

The complete statement from the KHBPA board of directors follows:

The Kentucky Horsemen’s Benevolent & Protective Association (KHBPA), unalterably opposes the recently announced plan of several North American tracks, including Keeneland and Churchill Downs, to run 2-year-old races without the anti-bleeder medication Lasix in 2020 and all stakes races in 2021. The KHBPA is the recognized representatives at all five Thoroughbred tracks in the Commonwealth.

It is untenable that the majority horsemen’s organization and equine medical professionals were not consulted before a fundamental policy change–banning Lasix on race-day–was unilaterally made by the racetracks. That would have provided the opportunity to stress the efficacy of Lasix in treating exercise-induced pulmonary hemorrhage (EIPH) in racehorses. Churchill Downs racetrack president Kevin Flanery, in a meeting with horsemen did indicate a willingness to discuss the issue following the running of the Kentucky Derby.

© 2015 IGSRV All rights reserved.